Clinical Trials Logo

Clinical Trial Summary

the investigators conduct a randomized, open-label trial to evaluate and compare the safety and efficacy of Xiyanping injection in patients with 2019-nCoV pneumonia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04275388
Study type Observational
Source Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Contact Hongzhou Lu, Master
Phone 021-37990333
Email lunliweiyuanhui2009@126.com
Status Not yet recruiting
Phase
Start date May 15, 2020
Completion date December 14, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04273646 - Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19 N/A